Table 4. Comparison of lateral flow chromatographic immunoassay (point-of-care antibody tests: NADAL® COVID-19 IgG/IgM rapid test; mö-screen 2019-NCOV coronavirus test) and reference standard for anti-SARS-CoV-2 antibodies (ELISA), using blood serum, in seven participants with detected SARS-CoV-2 antibodies